Advertisement

Pharmaceutisch weekblad

, Volume 1, Issue 1, pp 712–719 | Cite as

Stability of corticosteroids under anaerobic conditions

I. 17-deoxyprednisolone
  • D. Dekker
Original Articles

Abstract

One of the identified decomposition products formed during the anaerobic decomposition of prednisolone, is 17-deoxyprednisolone.

The Chromatographic properties, the isolation and the structure elucidation of the 17-deoxyprednisolone are given. Also a mechanism leading to this compound is postulated.

Keywords

Prednisolone Chromatographic Property Parent Peak Pharmaceutisch Weekblad Scientific Edition High Pressure Liquid Chromato 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen, A. E., andV. Das Gupta (1974)J. Pharm. Sci. 63, 107.CrossRefPubMedGoogle Scholar
  2. Barton, D. H. R., andW. C. Taylor (1958)J. Am. Chem. Soc. 80, 244.CrossRefGoogle Scholar
  3. Boer, H. S. De, J. Den Hartigh, H. H. J. L. Ploegmakers andW. J. Van Oort (1978)Anal. Chim. Acta 102, 141.CrossRefGoogle Scholar
  4. Chulski, T., andA. A. Forist (1958)J. Am. Pharm. Assoc. Sci. Ed. 47, 553.CrossRefGoogle Scholar
  5. Chulski, T., andD. J. Lamb (1963)J. Pharm. Sci. 52, 169.CrossRefPubMedGoogle Scholar
  6. Compernolle, F., andH. Vanderhaeghe (1970)Chrom. Symp. VI. Brussels, p. 526.Google Scholar
  7. Compernolle, F., H. Vanderhaeghe andM. Nonclercq (1972)J. Pharm. Pharmacol. 24, 429.CrossRefPubMedGoogle Scholar
  8. Dekker, D. (1979)J. Chromatog. 168, 508.CrossRefGoogle Scholar
  9. Görög, S., andP. Horváth (1978)Analyst 103, 346.CrossRefGoogle Scholar
  10. Guttman, D. E., andF. D. Meister (1958)J. Am. Pharm. Assoc. Sci. Ed. 47, 773.CrossRefGoogle Scholar
  11. Kawamura, M., R. Yamamoto andS. Fujisawa (1971)Yakugaku Zasshi 91, 863.PubMedGoogle Scholar
  12. Kuizenga, A. J., H. J. De Vos andM. H. Voorhuis (1973)Pharm. Weekblad 108, 809.Google Scholar
  13. Marcus, A. D. (1960)J. Am. Pharm. Assoc. Sci. Ed. 49, 383.CrossRefGoogle Scholar
  14. Mason, H. L. (1938)Proc. Staff Meetings Mayo Clinic 13, 235.Google Scholar
  15. Mauger, J. W., A. N. Paruta andR. J. Gerraughty (1969)J. Pharm. Sci. 58, 574.CrossRefPubMedGoogle Scholar
  16. Oesterling, T. O., andD. E. Guttman (1964)J. Pharm. Sci. 53, 1189.CrossRefPubMedGoogle Scholar
  17. Pitman, I. H., T. Higuchi, M. Alton andR. Wiley (1972)J. Pharm. Sci. 61, 918.CrossRefPubMedGoogle Scholar
  18. Shapiro, R. H., andC. Djerassi (1964)J. Am. Chem. Soc. 86, 2825.CrossRefGoogle Scholar
  19. Wendler, H. S. (1967)Molecular Rearrangements, Part Two (P. Mayo Ed.). Interscience, New York, p. 1068.Google Scholar
  20. Wendler, N. L., andR. P. Graber (1956)Chem. and Ind. (London), p. 549.Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1979

Authors and Affiliations

  • D. Dekker
    • 1
  1. 1.Department of Analytical Pharmacy, Faculty of PharmacyState UniversityUtrechtThe Netherlands

Personalised recommendations